Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 104

Results For "Import"

1693 News Found

Gufic Biosciences to grab a major share of Rs. 3,000 crore lyophilized antibacterial market
News | June 07, 2022

Gufic Biosciences to grab a major share of Rs. 3,000 crore lyophilized antibacterial market

The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price


Apollo Speciality Hospitals, Vanagaram organises vertigo awareness bicycle rally
Healthcare | June 06, 2022

Apollo Speciality Hospitals, Vanagaram organises vertigo awareness bicycle rally

The rally attracted around 250 riders, including professionals and amateurs.


Merck’s pembrolizumab demonstrates improvement in distant metastasis
News | June 06, 2022

Merck’s pembrolizumab demonstrates improvement in distant metastasis

Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).


Susanne Kaestner and Thea Boehm join ProBioGen
People | June 04, 2022

Susanne Kaestner and Thea Boehm join ProBioGen

Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.


Phygital model of med-tech seems to be quite Promising: opines Expert
Healthcare | June 04, 2022

Phygital model of med-tech seems to be quite Promising: opines Expert

To address the preventive & primary healthcare delivery gaps in India


Indian pharma market to grow at a CAGR of 12.3% to US$130 bn
News | June 04, 2022

Indian pharma market to grow at a CAGR of 12.3% to US$130 bn

PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030


Mitsubishi Tanabe Pharma America presents 48-week results from phase 3 safety clinical study of Radicava ORS
News | June 03, 2022

Mitsubishi Tanabe Pharma America presents 48-week results from phase 3 safety clinical study of Radicava ORS

Radicava ORS was approved by the U.S. Food and Drug Administration (FDA) on May 12, 2022


Evonik to build new lipid production facility for mRNA-based therapies in U.S.
News | June 03, 2022

Evonik to build new lipid production facility for mRNA-based therapies in U.S.

Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025


Digitalization of pharma labs will help in better decision making: Experts
Digitisation | June 02, 2022

Digitalization of pharma labs will help in better decision making: Experts

Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth


Moderna to become marketing authorization holder in Japan for Spikevax
News | June 01, 2022

Moderna to become marketing authorization holder in Japan for Spikevax

Companies concluded memorandum of understanding that Takeda will continue to provide distribution support for the Moderna COVID-19 vaccines for a transitional period